Table 2.
First Author | Year | Study Purpose/ Hypothesisa | Design/ Follow-up | Quality Ratingb | Sample | Setting | Primary Dependent Variablea | BDNF-related Findingsc |
---|---|---|---|---|---|---|---|---|
Metabolic syndrome | ||||||||
Chaldakov | 2004 | To study the cardiovascular and metabolic biology of nerve growth factor, BDNF and mast cells. | Case control | Poor | 33 adults (23 with metabolic syndrome, 10 healthy without metabolic syndrome) Age M 44.3 (2.7) 81.8% women |
Clinic | Plasma BDNF levels Nerve growth factor Mast cells |
Plasma BDNF levels were lower in participants with metabolic syndrome compared to participants without metabolic syndrome. |
Lee | 2012 | To examine the relationship of metabolic syndrome, adipose tissue and biomarkers with BDNF in men. | Case control | Fair | 58 men (34 with metabolic syndrome but not diabetes; 24 age-matched men without metabolic syndrome) Age M 40.2 (10.4) |
Clinic | Serum BDNF levels • Collected after an overnight fast |
There was no significant difference in serum BDNF levels between men with or without metabolic syndrome. There were no significant differences in the components of metabolic syndrome between those with low and those with high serum BDNF levels, except for lower systolic blood pressure in participants with high serum BDNF levels. |
Coronary artery disease | ||||||||
Bozzini | 2009 | To investigate the possible roles of BDNF Val66Met, 5-HTTLPR and −1438 G/A polymorphisms in CAD in patients with and without depression. | Case control | Fair | 242 adults (99 patients with CAD, 143 healthy control participants) 43.8% women 100% White |
Clinic | BDNF gene | The frequency of Met/Met genotype was significantly higher in the patients with CAD compared to the control cases. |
Bus | 2011 | To examine the determinants (sampling characteristics, socio-demographic variables, lifestyle indicators, CAD, and metabolic syndrome) of serum BDNF in a large and well-defined cohort of people without current psychiatric or neurologic diseases. | Cross-sectional | Poor | 1168 adults with subthreshold depressive or anxiety symptoms, or had high risk Age M 42.5 (14.1) 65% women |
Clinic | Serum BDNF levels • Collected after an overnight fast • Immediately transferred and processed within 1 hour |
Higher serum BDNF levels were found in participants who were older, had higher degrees of urbanicity, current smokers, and had metabolic syndrome or CAD. Significance for both metabolic syndrome and cardiovascular disease was lost controlling for age. Eating prior to blood withdrawal resulted in a significantly lower serum BDNF levels. Sampling later in the morning resulted in lower serum BDNF levels and longer sample storage. |
Sustar | 2016 | To evaluate the association between BDNF Val66Met (rs6265) polymorphism and CHD and/or BMI in patients with CHD and in healthy control participants. Hypothesis: Different BDNF Val66Met genotypes would be associated with CHD or with increased BMI in CHD patients and healthy control participants. | Case control | Good | 704 adults (206 with CHD, 498 healthy control participants) Age M 54.2 years 100% White |
Clinic | BDNF gene | There were no significant differences of BDNF genotype frequencies by sex and between adults with CHD and healthy control participants. BDNF rs6265 polymorphism was associated with BMI categories. |
Myocardial infarction | ||||||||
Lorgis | 2010 | To evaluate the relationship between BDNF, functional parameters and biological markers associated with inflammatory processes and platelet activation. | Case control | Good | 40 adults (20 with acute myocardial infarction, 20 age- and gender-matched with stable angina) Age Mdn 61.5 years (IQR = 54–78) 25% women |
Clinic | Serum BDNF levels • Collected in the morning after an overnight fast |
Median serum BDNF levels were significantly higher in the myocardial infarction group than in the stable angina group. In patients with myocardial infarction, a significant correlation was found between BDNF and sP-selectin. |
Zhang | 2015 | To identify serum biomarkers, including BDNF, of patients with STEMI for use in diagnosis | Case control | Fair | 20 men (10 with STEMI, 10 healthy without STEMI) Age M 54.2 (5.8) |
Hospital | Serum BDNF levels | Serum BDNF levels were significantly higher in the STEMI group compared with control cases. |
Heart failure | ||||||||
Pressler | 2015 | To examine the efficacy of Brain Fitness cognitive training intervention on memory in patients with heart failure, and to examine changes in serum BDNF levels between patients who were randomized to Brain Fitness and health education who were BDNF gene Met negative (homozygous Val/Val) and patients who were BDNF gene Met positive (heterozygous Val/Met and homozygous Met/Met). Hypothesis: Compared with heart failure patients in the active control health education group, heart failure patients who receive Brain Fitness have improved memory and serum BDNF levels. | RCT testing a cognitive training intervention (Brain Fitness) 12 weeks |
Good | 27 adults with heart failure Age M = 61.0 (11.9) 22% women 85.2% White 11.1% Black 3.7% Asian |
Clinic | Serum BDNF levels BDNF gene |
Serum BDNF levels significantly increased among patients who completed the intervention and decreased among patients who completed health education control at 12 weeks. There were no significant differences in memory between the groups over time. The intervention was associated with increased serum BDNF levels regardless of BDNF Met status. |
Pressler | 2017 | To characterize major allelic frequency of 2 variants in APOE gene in patients with heart failure, and evaluate differences in memory and serum BDNF levels based on APOE ε 4 allele(s). | One-group pre-post design testing a cognitive training intervention 8 weeks 12 weeks |
Fair | 26 adults with heart failure Age M 60.8 (12.1) |
Clinic | Serum BDNF levels | There were no significant differences in serum BDNF levels between those who had the APOEε4 allele and those who did not. None of the participants who had APOE ε 4 present had the BDNF Met allele. |
Takashio | 2015 | To evaluate plasma BDNF levels in patients with heart failure and age- and gender-matched control participants. Hypothesis: Plasma BDNF levels would be decreased in patients with heart failure. | Case control | Fair | 242 heart failure patients, 80 case control participants Age M 71 (12) 34% women |
Hospital | Plasma BDNF levels | Plasma BDNF levels were significantly lower in patients with heart failure and lower in patients with heart failure with NYHA class III than class I. |
Stroke | ||||||||
Lasek-Bal | 2015 | To assess the role of BDNF concentration in the course of ischemic stroke and its effect on post-stroke disability prognosis. | Longitudinal 90 days |
Good | 87 adults with ischemic stroke Age M 71.7 (11.8) 48.3% women |
Hospital | Serum BDNF levels • On the first day of stroke |
There were no significant differences between adults who had mild vs. moderate/severe neurological deficits on the first day post-stroke. Serum BDNF levels were significantly lower in adults with lower functional status at 90 days after the onset of stroke. |
Stanne | 2016 | To investigate whether circulating concentrations of BDNF are altered in the acute phase of ischemic stroke and whether they are associated with short- or long-term functional outcomes. Hypothesis: Circulating BDNF concentrations are lowered in the acute phase of ischemic stroke and low BDNF concentrations are associated with poor short- and long-term functional outcomes | Case control | Fair | 491 adults after stroke, 513 case control participants (1004 total) Age Mdn 58.5 (IQR = 51–64) 36% women 100% White |
Clinic | • Serum BDNF levels | Serum BDNF levels were significantly lower in adults after ischemic stroke compared with healthy control participants. Serum BDNF levels were not significantly associated with 3-month outcomes. In adults after ischemic stroke, those with the lowest tertile of BDNF had an increased risk of experiencing poor outcomes both at follow-up at 2 and 7 years. |
Other | ||||||||
Costa | 2014 | To evaluate the acute effect of aerobic exercise on the BDNF levels in adults with Chagas heart disease and the relationship between BDNF and ventricular dysfunction and exercise intensity. | Case control | Fair | 30 patients with Chagas heart disease (16 non-dilated, 14 dilated) Age M 47.9 (8.7) 33.0 % women |
Clinic | Serum BDNF levels • Collected immediately after exercise |
There was a significant decrease in serum BDNF levels after acute exercise across groups. The non-dilated group showed a significant decrease in serum BDNF levels. Patients who completed exercise at a high intensity had a significant decrease in serum BDNF levels compared to patients at moderate intensity. |
Ejiri | 2005 | To examine neurotrophin plasma levels in development of CAD and compare the levels in coronary circulation in with stable and unstable angina and without CAD | Cross-sectional | Fair | 107 adults (45 with stable angina, 38 with unstable angina, 24 without CAD) Age M 64.8 36% women |
Hospital | Plasma BDNF levels • Obtained from human coronary arteries |
The difference in BDNF levels between the coronary sinus and aorta was significantly greater in adults with unstable angina group compared with adults the stable angina and adults without CAD. |
Sanchez-DeToledo | 2014 | To determine the utility of non-invasive bedside neuromonitoring, including serum biomarkers (including serum BDNF), in identifying children at risk from adverse neurological outcome after heart surgery. Hypothesis: Two non-invasive neurological monitoring tools (including serum BDNF) would predict short-term adverse neurological outcomes. | Longitudinal 16 hours, 12 months |
Good | 36 children undergoing heart surgery with cardiopulmonary bypass Age Mdn 8 months (IQR = 1–20) |
Hospital | Serum BDNF levels • Collected at baseline, immediately after and 16 hours after surgery |
There were no significant differences in the levels of serum BDNF at baseline and immediately after and 16 hours after surgery between children with adverse neurological outcomes and children with good neurological outcomes at 12 months after surgery. |
Schutte | 2016 | To investigate associations between cardiometabolic risk markers, cortisol and cortisol:BDNF ratio in a bi-ethnic cohort | Cross-sectional | Fair | 406 adults Age M 44.7 (9.5) 50.7% women 51.5% White 58.5% African |
Clinic | Cortisol:serum BDNF ratio | Cortisol levels were lower in African men. BDNF was lower in African women compared to White women. In Africans (particularly men), higher cortisol:BDNF ratios were significantly associated with hyperglycemia, elevated 24-hour blood pressure, and silent ischemia. |
As reported in the study publications.
Quality ratings were determined by the National Heart, Lung, and Blood Institute Study Quality Assessment Tools, with the appropriate tool chosen by the design.
Adjusted model findings reported as available.
Note. BDNF = brain-derived neurotrophic factor. CAD = coronary artery disease. NYHA = New York Heart Association Classification. STEMI = ST-Elevation Myocardial Infarction. BMI = body mass index. CHD = coronary heart disease